SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-075011
Filing Date
2024-06-18
Accepted
2024-06-18 17:08:06
Documents
4
Effectiveness Date
2024-06-18

Document Format Files

Seq Description Document Type Size
1 S-8 2021_equity_plan_exp_s-8.htm S-8 138324
2 EX-5.01 revb-ex5_01.htm EX-5.01 15494
3 EX-23.01 revb-ex23_01.htm EX-23.01 4267
4 EX-FILING FEES revb-exfiling_fees.htm EX-FILING FEES 72561
  Complete submission text file 0000950170-24-075011.txt   231826
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280313 | Film No.: 241052904
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)